Wall Street analysts project Keurig Dr Pepper (KDP) Q2 EPS at $0.49, an 8.9% year-over-year increase, and revenues at $4.14 billion, up 5.5%. The consensus EPS estimate saw a 0.4% upward revision in the past 30 days, a factor often linked to potential investor reaction. While U.S. Refreshment Beverages are expected to drive growth with a 10.5% sales increase, U.S. Coffee and International net sales are forecast to decline slightly, though U.S. Coffee operating income is projected higher. KDP's stock has recently underperformed the broader market, holding a Zacks Rank #3 (Hold).
Keurig Dr Pepper (KDP) is positioned for top and bottom-line growth in its upcoming Q2 earnings report, with Wall Street consensus forecasting an 8.9% year-over-year increase in EPS to $0.49 and a 5.5% rise in revenue to $4.14 billion. Notably, the consensus EPS estimate has been revised upward by 0.4% over the past 30 days, a historically positive indicator for short-term stock performance. A granular look at segment expectations reveals a significant divergence in performance. The U.S. Refreshment Beverages division is the primary growth engine, with analysts projecting a 10.5% jump in net sales to $2.66 billion and a 12.2% increase in adjusted operating income. Conversely, both the U.S. Coffee and International segments are expected to report sales declines of 3.1% and 2.2%, respectively. A key operational insight is the projected 15.9% increase in U.S. Coffee's adjusted operating income despite falling sales, suggesting strong margin expansion or favorable pricing. This contrasts with the stock's recent underperformance, having returned -0.1% over the past month against the S&P 500 composite's +5.4% gain, setting the stage for a potentially pivotal earnings release.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment